Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by RWTH Aachen University
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
RWTH Aachen University
ClinicalTrials.gov Identifier:
NCT02066662
First received: February 17, 2014
Last updated: March 4, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2016
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)